51 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 19346648 | STABLE FORMULATIONS OF PROGRAMMED DEATH RECEPTOR 1 (PD-1) ANTIBODIES AND METHODS OF USE THEREOF | GODDARD, LAURA B | 1642 | Non-Final OA | Oct 01, 2025 |
| 19346638 | STABLE FORMULATIONS OF PROGRAMMED DEATH RECEPTOR 1 (PD-1) ANTIBODIES AND METHODS OF USE THEREOF | BALLARD, KIMBERLY | 1675 | Non-Final OA | Oct 01, 2025 |
| 18577775 | METHOD FOR ANALYZING TRACE LEVELS OF SEMI-VOLATILE NITROSAMINES IN SOLID SAMPLES | SINGER, DAVID L | 2855 | Non-Final OA | Jan 09, 2024 |
| 18405772 | HIGH CONCENTRATION SOLUTION ANTIBODY FORMULATIONS COMPRISING ANTI-IL-23p19 ANTIBODIES | JIANG, DONG | 1674 | Non-Final OA | Jan 05, 2024 |
| 18564799 | SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT | MOORE, SUSANNA | 1624 | Non-Final OA | Nov 28, 2023 |
| 18557487 | SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT | YOUNGBLOOD, WILLIAM JUSTIN | 1629 | Non-Final OA | Oct 26, 2023 |
| 18555640 | SMALL MOLECULE INHIBITORS OF KRAS G12D MUTANT | OH, TAYLOR V | 1625 | Non-Final OA | Oct 16, 2023 |
| 18484485 | BLOW-FILL SEALING METHOD FOR FILLING AND PACKAGING | LUK, EMMANUEL S | 1744 | Non-Final OA | Oct 11, 2023 |
| 18553774 | NOVEL FORMS OF CYCLIC DINUCLEOTIDE COMPOUNDS | VANHORN, ABIGAIL LOUISE | 1636 | Non-Final OA | Oct 03, 2023 |
| 18550332 | PLASMA KALLIKREIN INHIBITORS | JARRELL, NOBLE E | 1699 | Non-Final OA | Sep 13, 2023 |
| 18550348 | A CLOSED-SYSTEM UPSTREAM MANUFACTURING PROCESS FOR DENGUE VIRUS PRODUCTION | TANG, JIANMING | 1671 | Non-Final OA | Sep 13, 2023 |
| 18548640 | REDUCING HIGH MANNOSE GLYCAN PROTEIN EXPRESSION USING GUANOSINE 5'-MONOPHOSPHATE | HOLLAND, PAUL J | 1656 | Non-Final OA | Sep 01, 2023 |
| 18263277 | LIPID NANOPARTICLE ADJUVANT COMPOSITION FOR PNEUMOCOCCAL CONJUGATE VACCINES | MORGAN, BAILEY MICHELLE | 1645 | Non-Final OA | Jul 27, 2023 |
| 18348787 | DENSIFIED CO-PRECIPITATED MATERIALS ISOLATED BY THIN FILM EVAPORATION | GOTFREDSON, GAREN | 1619 | Non-Final OA | Jul 07, 2023 |
| 18346315 | NOVEL SYNTHETIC PATHWAY TO BELZUTIFAN | SWIFT, CANDICE LEE | 1657 | Non-Final OA | Jul 03, 2023 |
| 18258397 | IL-2 MUTEINS FOR TREATING AUTOIMMUNE AND INFLAMMATORY DISEASES | GURLEY, JAMI MICHELLE | 1647 | Non-Final OA | Jun 20, 2023 |
| 18256943 | MINI-TABLET DOSAGE FORM OF A VIRAL TERMINASE INHIBITOR AND USES THEREOF | KASSA, TIGABU | 1619 | Non-Final OA | Jun 12, 2023 |
| 18256997 | FUSED BICYCLIC PYRAZOLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF HERPESVIRUSES | JOHNSON, CHRISTOPHER LINDSAY | 1691 | Final Rejection | Jun 12, 2023 |
| 18317377 | SYRINGES AND INJECTORS WITH CAPACITIVE SENSING AND METHODS OF MAKING AND USING SAME | SHAH, NILAY J | 3783 | Non-Final OA | May 15, 2023 |
| 18252217 | 3-AMINO PYRROLIDINE AND PIPERIDINE MACROCYCLIC OREXIN RECEPTOR AGONISTS | COLEMAN, BRENDA LIBBY | 1624 | Final Rejection | May 09, 2023 |
| 18251314 | ANTI-RESPIRATORY SYNCYTIAL VIRUS (RSV) ANTIBODY CELL-BASED POTENCY ASSAY | BURKHART, MICHAEL D | 1638 | Non-Final OA | May 01, 2023 |
| 18251259 | DIAMINOPYRIMIDINE CARBOXAMIDE INHIBITORS OF HPK1 | WHITE, DAWANNA SHAR-DAY | 1627 | Final Rejection | May 01, 2023 |
| 18250404 | METHODS FOR TREATING HEMATOLOGIC MALIGNANCIES WITH AMINO-PYRROLOPYRIMIDINONE COMPOUNDS | OTTON, ALICIA L | 1699 | Non-Final OA | Apr 25, 2023 |
| 18246467 | STABLE FORMULATIONS OF PROGRAMMED DEATH RECEPTOR 1 (PD-1) ANTIBODIES AND HYALURONIDASE VARIANTS AND FRAGMENTS THEREOF AND METHODS OF USE THEREOF | CHHAY, BONIRATH | 1645 | Non-Final OA | Mar 23, 2023 |
| 18246408 | CORONAVIRUS REPLICONS FOR ANTIVIRAL SCREENING AND TESTING | KONOPKA, CATHERINE ANNE | 1635 | Non-Final OA | Mar 23, 2023 |
| 18043357 | PLASMA KALLIKREIN INHIBITORS | HERNANDEZ, JACKSON J | 1627 | Final Rejection | Feb 28, 2023 |
| 18041815 | INSULIN RECEPTOR PARTIAL AGONISTS | BEANE, RANDALL L | 1654 | Non-Final OA | Feb 16, 2023 |
| 18021369 | CO-STIMULATORY 4-1BBL ECTODOMAIN POLYPEPTIDES FOR IMMUNOMODULATION | HELLMAN, KRISTINA M | 1654 | Non-Final OA | Feb 14, 2023 |
| 18015671 | CYCLIC CYANOENONE DERIVATIVES AS MODULATORS OF KEAP1 | O DELL, DAVID K | 1621 | Non-Final OA | Jan 11, 2023 |
| 18015364 | ADENOSINE A2A AND A2B RECEPTOR DUAL ANTAGONISTS FOR IMMUNO-ONCOLOGY | HERNANDEZ, JACKSON J | 1627 | Non-Final OA | Jan 10, 2023 |
| 18015387 | ADENOSINE A2A AND A2B RECEPTOR DUAL ANTAGONISTS FOR IMMUNO-ONCOLOGY | HERNANDEZ, JACKSON J | 1627 | Non-Final OA | Jan 10, 2023 |
| 18007776 | RIPK1 INHIBITORS AND METHODS OF USE | HERNANDEZ, JACKSON J | 1627 | Final Rejection | Dec 02, 2022 |
| 17927222 | PYRAZOLO[4,3-d]PYRIMIDINE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF CELLULAR PROLIFERATIVE DISORDERS | SAMSELL, RILLA MARIE | 1624 | Non-Final OA | Nov 22, 2022 |
| 17920876 | MODULAR BLENDER AND METHOD OF USING SAME | SORKIN, DAVID L | 1774 | Non-Final OA | Oct 24, 2022 |
| 17935856 | PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC POLYSACCHARIDE-CARRIER PROTEIN CONJUGATES | DEVI, SARVAMANGALA | 1645 | Final Rejection | Sep 27, 2022 |
| 17934396 | PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC POLYSACCHARIDE-CARRIER PROTEIN CONJUGATES | DEVI, SARVAMANGALA | 1645 | Non-Final OA | Sep 22, 2022 |
| 17934379 | PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC POLYSACCHARIDE-CARRIER PROTEIN CONJUGATES | DEVI, SARVAMANGALA | 1645 | Final Rejection | Sep 22, 2022 |
| 17817382 | HPV VACCINE | ZOU, NIANXIANG | 1671 | Non-Final OA | Aug 04, 2022 |
| 17793583 | DRUG DELIVERY SYSTEM FOR THE DELIVERY OF STEROID TO VITREOUS CHAMBER OF THE EYE | BABSON, NICOLE PLOURDE | 1619 | Final Rejection | Jul 18, 2022 |
| 17789374 | ARGINASE INHIBITORS AND METHODS OF USE | WILSON, JERICA KATLYNN | 1621 | Non-Final OA | Jun 27, 2022 |
| 17785750 | NON-INVASIVE CONTINUOUS CAPACITANCE LEVEL DETECTOR | DEVITO, ALEX T | 2855 | Non-Final OA | Jun 15, 2022 |
| 17785772 | STAPLED OLEFIN CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS | KONOPELSKI SNAVEL, SARA ELIZABETH | 1658 | Final Rejection | Jun 15, 2022 |
| 17785279 | STAPLED LACTAM CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS | BRADLEY, CHRISTINA | 1654 | Final Rejection | Jun 14, 2022 |
| 17785287 | STAPLED TRIAZOLE CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS | BRADLEY, CHRISTINA | 1654 | Final Rejection | Jun 14, 2022 |
| 17784718 | INDAZOLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF HERPES VIRUSES | YOUNGBLOOD, WILLIAM JUSTIN | 1629 | Non-Final OA | Jun 13, 2022 |
| 17783938 | USE OF BIOMARKERS IN IDENTIFYING PATIENTS THAT WILL BE RESPONSIVE TO TREATMENT WITH A PRMT5 INHIBITOR | KONOPKA, CATHERINE ANNE | 1635 | Final Rejection | Jun 09, 2022 |
| 17779427 | IN VITRO CELL BASED POTENCY ASSAY | TAKENAKA, RISA | 1632 | Final Rejection | May 24, 2022 |
| 17642870 | METHODS AND COMPOSITIONS COMPRISING AN ANTI-CTLA4 MONOCLONAL ANTIBODY WITH REDUCED HOST CELL PROTEINS AND INCREASED POLYSORBATE-80 STABILITY | DUFFY, BRADLEY | 1643 | Non-Final OA | Mar 14, 2022 |
| 17614865 | AN IMMUNOGENIC SEROTYPE 35B PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE AND CONJUGATION PROCESS FOR MAKING THE SAME | KOLKER, DANIEL E | 1645 | Final Rejection | Nov 29, 2021 |
| 17482650 | Stable Formulations of Programmed Death Receptor 1 (PD-1) Antibodies and Hyaluronidase Variants and Fragments Thereof and Methods of Use Thereof | BENAVIDES, JENNIFER ANN | 1675 | Final Rejection | Sep 23, 2021 |
| 17093833 | OXAZOLIDINONE COMPOUNDS AND METHODS OF USE THEREOF AS ANTIBACTERIAL AGENTS | PATEL, SAGAR S | 1626 | Non-Final OA | Nov 10, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial